Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-002486

ARMO BioSciences, Inc. · ARMO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jan 30, 2018
Accepted (ET)
Feb 1, 2018 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001693664

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 30, 2018C809,800—A809,800IBy SCC Venture VI Holdco, Ltd.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series C-1 Preferred StockF2,F1—Jan 30, 2018C809,800D——Common Stock809,8000I

Explanation of responses

Remarks

* /s/ Jung Yeon Son, by power of attorney for Neil Nanpeng Shen, an authorized signatory of SC China Holding Limited, the general partner of SC China Venture VI Management L.P., the general partner of Sequoia Capital China Venture VI, L.P., the sole member of SCC Venture VI Holdco, Ltd.